Objective-Proinflammatory cytokines contribute to the development of retinal vasculopathies. However, the role of these factors and the mechanisms by which they elicit their effects in retina are not known. We investigated whether activated microglia during early stages of ischemic retinopathy produces excessive interleukin-1β (IL-1β), which elicits retinal microvascular degeneration not directly but rather by triggering the release of the proapoptotic/repulsive factor semaphorin-3A (Sema3A) 
I schemic vasoproliferative retinopathies characterized by a retinal microvascular degeneration followed by an abnormal intravitreal neovascularization have recently been associated with neuroinflammatory responses. [1] [2] [3] Interleukin-1β (IL-1β), a major mediator of inflammation, [4] [5] [6] has generally been implicated in the development of vasoproliferative retinopathies, such as in diabetes mellitus 7 and choroidal neovascularization. 8, 9 Yet, IL-1β exerts neurotoxicity, 2,10,11 vascular repulsion, 1 capillary degeneration, 12 induction of neovascular tumor growth, [13] [14] [15] and seems to modulate angiogenesis by directly interacting with vascular endothelial cells or by enhancing the production of proangiogenic factors in a paracrine manner. 6, [16] [17] [18] In the eye, under ischemic conditions, IL-1β is markedly increased in neutrophils recruited into the retina, endothelial, and retinal glial cells. 19 Microglia are phagocytic sentinels in the central nervous system, including the retina, and are also needed for neuronal homeostasis and innate immune defense. 20, 21 However, under severe insults, including hypoxic/ischemic injury, microglia become overactivated and function as a prominent source of cytotoxic oxidant stress and proinflammatory factors. [22] [23] [24] In this regard, microglial overactivation can contribute to the production of IL-1β, tumor necrosis factor-α, and IL-6 found in high concentrations in tissues of patients and animals with vasoproliferative retinopathy, [25] [26] [27] and have been linked to the development of ischemic retinopathies in humans 28 and animal models. 27, 29, 30 IL-1β exerts its biological effects by interacting with the IL-1 receptor type I (IL-1RI), which is composed of a ligand-binding unit and a signaling unit named the accessory protein . 4 This activity is modulated endogenously by the natural IL-1 receptor antagonist (IL-1Ra), a 17.5-kDa protein that competes with IL-1 for its binding site on IL-1RI. 31 ,32 IL-1Ra is considered an important endogenous anti-inflammatory cytokine that blocks all known actions of IL-1β. Previous studies have shown that recombinant IL-1Ra (Kineret) protects against IL-1β and excitotoxin-induced neurotoxicity. 33 In vitro, the presence of IL-1Ra has been shown to transform amoeboid microglia into ramified cells, 34 and inhibit endothelial cell death induced by IL-1β by decreasing nuclear factor κB and caspase-3 activation. 7 IL-1Ra-deficient mice are susceptible to neuronal injury after cerebral ischemia 35 and, conversely, recombinant IL-1Ra attenuates the neurotoxicity. 36 Intravitreal IL-1Ra also markedly reduces laser-induced choroidal neovascularization. 8 Our laboratory recently highlighted the influence of neuron-derived signaling molecules on endothelial cell function in the retina. 1 These signals include classic neuronal guidance cues, particularly the class III semaphorins, implicated among its functions in inducing apoptosis. 37, 38 However, the specific interplay of microglia and neurons in the pathogenesis of ischemic retinopathies (such as of prematurity [and diabetes mellitus]), particularly as it applies to IL-1β, on the critical vascular degenerative component, which precedes the aberrant vasoproliferative phase, is not known.
In this work, we found in the oxygen-induced model of retinopathy of prematurity associated with prominent retinal vaso-obliteration (a sine qua non to subsequent preretinal vasoproliferation) that hyperoxia activates microglia in the retina to produce IL-1β, which sustains the activation of microglia and induces microvascular injury not directly, but through the release of proapoptotic/repulsive factor semaphorin-3A (Sema3A) from adjacent neurons. Administration of 2 distinct inhibitors of IL-1R (IL-1Ra, and an all-d [protease resistant] oligopeptide rytvela labeled 101.10 39 ) abrogated microglial activation, IL-1β release, and Sema3A expression in the retina and resulted in a significant decrease in vasoobliteration and acceleration of revascularization of the avascular retina in O 2 -induced retinopathy (OIR), as seen after knockdown of Sema3A.
Results

OIR Triggers Early Production of IL-1β and Other Inflammatory Mediators in the Retina; Inhibition of IL-1β Activity Decreases Inflammation and Retinal Vaso-Obliteration
Animals were subjected to OIR as described. 40 At postnatal day 6 (P6) after exposure to hyperoxia (80% O 2 ) for 20 hours, there was an increase in the retinal mRNA expression of the proinflammatory cytokine, IL-1β (4.1-fold; P<0.001), the microglial marker, Iba-1 (2.6-fold; P<0.01), and the cytotoxic factor, Sema3A (2.1-fold; P<0.05), as well as other inflammatory mediators, such as tumor necrosis factor-α (2.1-fold; P<0.01) and intercellular adhesion molecule-1 (1.5-fold; P<0.05), compared with the normoxic retinas ( Figure 1) ; interestingly, the major inflammasome protein NOD-like receptor family pyrin domain containing-3 (NLRP3) was also increased in retina of P6 and P8 hyperoxia-exposed pups ( Figure IA in the online-only Data Supplement). mRNA expression of endogenous IL-1Ra did not significantly increase, and that of Caspase-1 and vascular endothelial growth factor (VEGF) also remained unchanged (Figure 1 ). IL-1Ra and 101.10 (started at P5) significantly attenuated hyperoxia-induced changes in IL-1β, tumor necrosis factor-α, intercellular adhesion molecule-1, Iba-1, and Sema3A.
At P8, 72 hours after exposure to high oxygen, IL-1β and Iba-1 mRNA expression was greater than values in normoxia, albeit lower than those at P6 ( Figure 1) ; IL-1Ra decreased further to below normoxia values. In contrast, Caspase-1, intercellular adhesion molecule-1, and VEGF mRNA increased relative to values at P5, although tumor necrosis factor-α and Sema3A remained steady. Western blot analysis confirmed the hyperoxia-induced increase in IL-1β and Sema3A, whereas VEGF expression decreased ( Figure IB At P10, 120 hours after exposure to hyperoxia, the mRNA expression of all inflammatory and apoptotic factors subsided, whereas that of the anti-inflammatory IL-1Ra and of the cytoprotective VEGF increased relative to changes at P8 (during this vaso-obliterative phase).
Both antagonists of IL-1R prevented retinal vaso-obliteration and tended to renormalize vascular density of animals subjected to hyperoxia (Figure 2 ). Moreover, pups treated with both IL-1R antagonist starting at P8 (3 days after exposure to hyperoxia, which leads to vaso-obliteration) till P10 exhibited a significant increment in normal revascularization (compared with the vehicle-treated rats; Figure 2G ), as noted by a gradual decrease in vaso-obliteration; this was further substantiated by a lack of increase in VEGF by P10 (Figure 1 ). In control normoxic pups, IL-1Ra and 101.10 did not affect developmental retinal vascular density ( Figure II in the online-only Data Supplement), consistent with absence of inflammation under normal conditions. Hence, the overall decreased vaso-obliteration by IL-1R inhibitors tended to abolish the hypoxia-driven surge in VEGF ( Figure 1H To ascertain actions of the all-d peptide 101.10 in retina, its local distribution was studied. 101.10 was conjugated to fluorescein isothiocyanate (FITC), and fluorescence was detected by microscopy in retinas of injected animals. 101.10 localized principally in microglial and endothelial cells in normoxia-raised rats ( Figure IV in the onlineonly Data Supplement). Animals exposed to hyperoxic conditions exhibited a significant increase in vascular and perivascular fluorescence; FITC alone (not conjugated to 101.10) was negligibly detected in retina. Hence, 101.10 distributes in retina, more so during hyperoxia when IL-1R (to which 101.10 binds) 39 Together, these results reveal that hyperoxia induces an early increase in the expression of inflammatory mediators in the retina, and show that exogenous IL-1Ra and 101.10 comparably reduce the expression of these inflammatory components, and in turn protect the retina from retinal vascular degeneration, allowing for an accelerated normal vascular regrowth and preventing against ensued preretinal neovascularization.
Hyperoxia Leads to Activation of Microglia, Which in Turn Is the Main Generator of IL-1β in Retina
Increased Iba-1 mRNA expression in hyperoxic rats ( Figure 1B ) was suggestive of microglial activation. We elaborated on this observation by examining microglial Iba-1 immunoreactivity and morphology in situ. IL-1β was mostly found in the inner retina of hyperoxic rats (at P8), largely confined to microglia (Iba-1 immunopositive; a calcium-binding protein expressed by activated microglial cells; Figure 3 by hyperoxia (at P8), and found throughout all layers of the retina, consistent with its ubiquitous distribution ( Figure VII in the online-only Data Supplement); no immunoreactivity to isotype control antibody was detected.
On closer examination, one noted overall increased Iba-1 immunoreactive cells in retinas of hyperoxic rats compared with normoxic ones (Figure 3 ). Retinal microglia from normoxic rats possessed thin processes that branched as they extended from the cell soma (Figure 3) , characteristic of resting microglia. Microglia in retinas of hyperoxic rats were hypertrophied often with amoeboid shape, had fewer processes, which were thicker and shorter, consistent with differentiation into an activated phagocyte (Figure 3) . Treatment with inhibitors of IL-1R, IL-1Ra, or 101.10 renormalized the number of activated microglia as well as their morphology, which was more branched out similar to that in normoxic animals ( Figure 3) ; these observations along with those showing decreased Iba-1 mRNA in IL-1R inhibitor-treated animals ( Figure 1 ) suggested that IL-1β participates in the activation of microglia.
IL-1β Is Released From Microglial Cells Exposed to Hyperoxia In Vitro
Microglia is activated and IL-1β is released during the hyperoxia-induced vaso-obliteration in OIR (Figures 1 and 3 ). To confirm microglia as a prominent source of IL-1β under hyperoxic conditions, primary retinal microglial cells from pup rats at P6 were isolated and cultured ( Figure 4 ). Nearly all (>98%) of the isolated DAPI-positive cells from retinas of rats were immunopositive for the microglial specific marker Iba-1 ( Figure 4A ) as well as lectin Bandeiraea simplicifolia ( Figure 4B ); cells were immunonegative for macroglial marker glial fibrillary acidic protein ( Figure 4C ) and for neural marker neuronal nuclei ( Figure 4D Representative images of flatmounted retinas labeled with Griffonia simplicifolia lectin to examine vascularization at P8 (A) and at P10 (D); the central outline delimits the vaso-obliterated (VO) region. In the top panels (A-C), rat pups (n=5-6 per group) were treated with vehicle or IL-1R antagonists (IL-1Ra), and maintained in hyperoxia (80% oxygen) from P5 to P8 resulted; one notes a 26% central capillary dropout area (white areas) and 44% decrease in vascular density in controls (compared with pups exposed to 21% oxygen). Whereas IL-1Ra and 101.10 treatments significantly reduced the capillary dropout areas to ≈10% (B; #*P<0.05 vs hyperoxia [vehicle treated]), and increased vascular density to ≈85% (C; &P=0.001 vs normoxia, #*P<0.05 vs hyperoxia [vehicle] ). In lower panels (D-G), rat pups (n=5-6) were maintained in hyperoxia (80% oxygen) from P5 to P10 (D) and treated with vehicle or IL-1R antagonists from P8 (when vaso-obliteration was already present) until P10. In vehicle-treated animals, there was a 29% central capillary dropout area and 48% reduction in vascular density compared with the control. Treatment with both antagonists of IL-1R (starting at P8 and ending at P10; see arrows in G) reduced significantly the central capillary dropout area to ≈13% (E; #*P<0.05 vs hyperoxia [vehicle]), and increased vascular density to ≈78% (F), and promoted revascularization as noted by decrease in vaso-obliteration between P8 and P10 (G; &P<0.001 vs normoxia, #P<0.01 and *P<0.001 vs hyperoxia [vehicle] ).
Because hyperoxia results in oxidant stress in retina of young developing subjects, 41 we determined its role in inducing IL-1β. The antioxidant glutathione precursor N-acetyl cysteine markedly prevented hyperoxia-induced microglial activation as attested by diminished Iba-1, NLRP3, and IL-1β expression (Figure VIIIB-VIIIE in the online-only Data Supplement).
We also verified in isolated microglia whether IL-1β controls activation of microglia and stimulates further generation of IL-1β, as inferred in vivo using the inhibitors of IL-1R (Figure 1) . Indeed, stimulation of microglial cells with IL-1β induced Iba-1 and IL-1β (mRNA) expression, and this effect was abrogated by inhibitors of IL-1R ( Figure 4G ). This autoamplification of IL-1β expression by exogenous IL-1β was reproduced in IL-1RI-expressing HEK cells as well as in raw-blue mouse macrophages ( Figure IXA 
Activation of Microglia Is Cytotoxic to Endothelial Cells Through IL-1β-Dependent Induction of Semaphorin-3A in RGCs
Because microglial activation and increased IL-1β are associated with vaso-obliteration during hyperoxia in vivo (Figures 2-4) , we next investigated in vitro whether conditioned media from activated microglia in culture (which contains IL-1β; Figure 4F ) or whether IL-1β is directly cytotoxic to retinal microvascular endothelial cells. Neither conditioned media from hyperoxia-exposed microglia nor exogenous IL-1β were directly cytotoxic to retinal microvascular cells ( Figure 4H and 4I). Interestingly, IL-1β has been reported to induce the release of the endothelial proapoptotic and repulsive cue Sema3A from RGCs.
1 First, we confirmed the contribution of Sema3A in vaso-obliteration as seen on exposure to hyperoxia (when IL-1β levels are high; Figure 1) . We started by showing that exposure to hyperoxia induced an increase in Sema3A expression specifically in RGCs, and that this increase was abolished by IL-1R antagonists (Figure X in the online-only Data Supplement). Then, we determined the role of Sema3A on vaso-obliteration using shRNA encoded in lentiviral vectors (Lv) as we previously reported. 1 Rat pups were injected at showed a predominant labeling of ramified, nonactivated microglia in animals exposed to normoxic conditions, whereas a large number of amoeboid/activated cells were present in retinas under hyperoxic conditions. Hyperoxic animals receiving IL-1Ra or 101.10 administrations displayed a reverse phenotype of microglia with long protrusions typical of resting microglia. Scale bar, 50 μm. INL indicates inner nuclear layer; IPL, inner plexiform layer; and OPL, outer plexiform layer.
P1 with lentiviral vector plasmid containing the small hairpin RNA against Sema3A and the contralateral (control) eye with Lv.shGFP; the shSema3a-but not the shGFP-encoded lentivirus knocked down Sema3A expression ( Figure 5 ). As anticipated, lentiviral vector plasmid containing the small hairpin RNA against Sema3A, but not Lv.shGFP (control), attenuated the OIR-associated vaso-obliteration at P8 ( Figure 5 ). We further explored the link between IL-1β and Sema3A. IL-1β induced a time-dependent increase in Sema3A mRNA expression in cultured RGCs, which was significantly attenuated by inhibitors of IL-1R ( Figure 6A) ; similar changes were seen on the protein by Western blot ( Figure IE in the online-only Data Supplement). In addition, RGCs stimulated with conditioned media from hyperoxia-exposed (24 hours) microglia (containing IL-1β; Figure 4F 38 In contrast, hyperoxia-exposed endothelial cells did not exhibit augmented IL-1β formation, and treatment of RGCs with conditioned media from hyperoxia-exposed endothelium did not cause endothelial cytotoxicity ( Figure XIIC and XIID in the online-only Data Supplement). Together with in vivo evidence that IL-1R inhibitors prevent the early hyperoxia-induced surge in Sema3A ( Figure 1C ; and Figure X in the online-only Data Supplement), the present findings strongly support an IL-1β-induced Sema3A expression and in turn endothelial cell death, consistent with Sema3A-dependent impaired vascular sprouting. Our results provide evidence for a role for IL-1β, (largely) from sustained activated microglia (Figures 3 and 4) , in contributing significantly to hyperoxia-induced vaso-obliteration through a mechanism involving the proapoptotic factor, Sema3A.
Discussion
A number of studies have proposed a role for inflammatory mediators in ischemic retinopathies. In this context, the major proinflammatory cytokine IL-1β has been suggested to contribute to the development of proliferative diabetic retinopathy in humans as well as in animal models, 7, 12, 25, 42 choroidal neovascularization and retinal degeneration 8, 9 ; its role in retinopathy of prematurity has never been specifically evaluated. On one hand, IL-1β is primarily associated with angiogenesis. 8, 9, 18, 43 Whereas, on the other hand, IL-1β has also been linked to retinal vascular degeneration 44 ; this latter aspect remains unexplained. Although microglia are thought to contribute significantly to the generation of cytokines in neural tissue, 2,45 their involvement in retinovascular degeneration is elusive; along these lines, microglia (nonactivated) are reported to participate in normal developmental angiogenesis. 46 In this study, we show that retinal microglia are overactivated during the vaso-obliteration phase of ischemic retinopathies, and serve as an important source of IL-1β, which induces vascular degeneration not directly but rather by stimulating the generation of proapoptotic/repulsive cue Sema3A from adjacent neurons. Inhibitors of the IL-R, notably exogenous recombinant IL-1Ra and the IL-1R modulator 101.10, 39 decreased microglial activation and IL-1β release, and in turn Sema3A expression, consequently diminishing vaso-obliteration, enhancing revascularization and, thus, attenuating resultant pathological preretinal neovascularization in the established model of OIR.
A major feature in this study applies to the pivotal role of microglia not only in generating IL-1β, but also through this cytokine in orchestrating neurovascular degeneration through the release of Sema3A. Although microglia are known to be in intimate contact with neovascular tufts 29, 30 because they guide the proliferating vascular bed, 46 mechanisms for their role in vascular degeneration is vague. We found that in response to hyperoxic stress, microglia are activated and release IL-1β (in vivo and in vitro), which in turn induces its endothelial cytotoxic effects via RGCderived Sema3A; our findings do not fully exclude a contribution of cytokines by other retinal cells. 19 Consistent with these findings, hyperoxic stress is tightly intertwined with inflammation 47 through receptors activated by products of peroxidation, such as CD36, 48 TLR4, and stimulation of the inflammasome 49 ; this oxidant stress 41 seems to explain the generation of IL-1β during hyperoxia as observed here and by others. 50 Conversely, we found that interfering with IL-1R actions preserved retinal vasculature, enhanced revascularization, and, as a result, prevented preretinal neovascularization. In this context, we observed that it is not so much the number of microglia that changes with the stress stimulus (hyperoxia) but rather their activation. These observations are consistent with microglial activation in human diabetic retinopathy 28 as well as in experimental ischemic retinopathies. 30 Interestingly, we also found that IL-1β maintains activation of microglia, and inhibition (or downregulation) of IL-1R prevents increased Iba-1 in microglia and IL1β expression in different cell types. Along these lines, inhibition of microglial activation (using minocycline) has been found to diminish cytokine release and reduce progression of ischemic retinopathy 27 ; whereas exogenous IL-1Ra reduces intercellular adhesion molecule-1 expression and reinstates microglial ramification (resting condition) 34 ; microglial activation is also reduced in IL-1R1 null mice subjected to hypoxic/ischemic insults. 51 Together our observations, supported by other reports, suggest an autoactivation of microglia through IL-1β.
In the present work, we uncover a new mechanism for IL-1β in inducing retinal microvascular degeneration, specifically by stimulating RGCs to produce the proapoptotic/ repulsive factor Sema3A. By 20 hours of hyperoxia, microglia were activated through an IL-1β-dependent process, resulting in release of IL-1β (along with other inflammatory markers) and (consequently) in Sema3A; this in vivo induction in IL-1β expression could be reproduced and better characterized in vitro on cultured microglia exposed to hyperoxia; in turn, IL-1β was also shown to induce Sema3A in isolated RGCs. Consequently, Sema3A was responsible for microvascular endothelial cell death (in vitro and in vivo); hence, inhibition of IL-1R or of Sema3A (antiSema3A, or through silencing shRNA-Sema3A) exerted a relative preservation of retinal endothelium. By 120 hours of hyperoxia (at P10), retinal vascular degeneration was found to be pronounced, resulting in a relatively hypoxic inner retina, which triggers an increase in VEGF expression in an attempt to reestablish O 2 supply; this does not exclude a direct role for IL-1β in inducing VEGF expression [52] [53] [54] ; however, there was a general suppression of inflammatory markers at P10 (compared with P8), which may be attributable to the relative increase in IL-1Ra. Interestingly, one also notes at P10 unaltered levels of Sema3A (compared with normoxia), consistent with a rate of vaso-obliteration, which decreases from P8-P10 compared with P5-P8. Inhibition of IL-1R prevents the early (P8) rise in Sema3A, which contributes to vaso-obliteration, and facilitates revascularization; re-establishment of the O 2 supply to the retina suppresses a hypoxia-driven surge in VEGF at P10. A schematic model depicting our overall observations is presented in Figure 8 .
A new aspect conveyed in this study applies to the efficacy of the IL-1R modulator 101.10 in ischemic retinopathies. This small stable peptide was as effective as recombinant IL-1Ra. Recombinant IL-1Ra is approved for rheumatoid arthritis, but exhibits certain drawbacks, such as pain at the site of administration, need for injection (rather than oral administration), and increased risk for infections. The allosteric modulator of IL-1R 101.10 may offer certain advantages, including possibly through its pharmacological selectivity diminish certain adverse effects such as the risk for infections. 39 101.10 may represent a prototype for a new class of small (molecule) inhibitors of IL-1R, which so far are all large molecules requiring parenteral administration. 55 In summary, we hereby present a critical role for IL-1β in contributing to the early (and consequently as well to the late) phase of OIR, by activating microglia that are major contributors in IL-1β generation; on one hand, IL-1β sustains microglial activation, and on the other induces adjacent RGCs to produce Sema3A. The latter causes microvascular degeneration contributing to the early vaso-obliteration detected in ischemic retinopathies, which predisposes to subsequent preretinal neovascularization. Distinct inhibitors of IL-1R, notably recombinant IL-1Ra and the modulator 101.10, prevent hyperoxia-induced microglial activation, the surge in IL-1β formation, retinal vaso-obliteration and, consequently, preretinal neovascularization. 
